New Findings Presented at LINC Show Promise for the Profusa Lumee™ Oxygen Platform to Measure Oxygen in Compromised Tissues in Peripheral Artery Disease (PAD) Patients - PRNewswire

New Findings Presented at LINC Show Promise for the Profusa Lumee™ Oxygen Platform to Measure Oxygen in Compromised Tissues in Peripheral Artery Disease (PAD) Patients  PRNewswire

LEIPZIG, Germany and SOUTH SAN FRANCISCO, Calif., Jan. 24, 2019 /PRNewswire/ -- Profusa today announced promising clinical data from two studies ...



Comments

Post a Comment

Popular posts from this blog

Orchestra BioMed™ Announces FDA Breakthrough Device Designation for Virtue® Sirolimus-Eluting Balloon for Treatment of Below-the-Knee Peripheral Artery Disease - Vascular Disease Management

Orchestra BioMed™ Announces FDA Breakthrough Device Designation for Virtue® Sirolimus-Eluting Balloon for Treatment of Below-the-Knee Peripheral Artery Disease    Vascular Disease Management First and only non-coated sirolimus-eluting angioplasty balloon system to receive Breakthrough Device designation for below-the-knee disease; Follows ...
Read more